McKesson Corporation
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specia…
What to know about MCK
McKesson Corporation is a large Healthcare company with a mixed financial profile. It scores well on risk and size, but profitability is worth keeping an eye on.
Should you consider MCK?
Based on 31 financial metrics and sector comparison. Not financial advice.
-
McKesson Corporation is a large-cap Healthcare company with a mixed overall financial profile — it is in the lower half of its Healthcare peers (33 of 59).
-
Profit margins are thin compared to most S&P 500 peers — the company keeps less of each dollar it earns than the average. Watch for signs of margin improvement.
-
Valuation looks attractive — the stock is priced reasonably relative to its earnings and sales compared to most peers. You're not overpaying for the business.
-
The company is growing at a reasonable pace — not the fastest, but consistently moving in the right direction.
-
There is a small dividend (0.00%), but income-focused investors will likely find better yields elsewhere in the market.
-
Risk is relatively low — the stock tends to be less volatile than the broader market, which typically means a smoother ride during uncertain periods.
-
Analyst sentiment is broadly positive and short interest is low — professionals who cover this stock are mostly optimistic about its near-term prospects.
-
This is a mixed picture — real strengths in some areas, but areas that need watching too. Do your homework on the sector before deciding.
At a glance
How it scores
We look at 31 different financial metrics and group them into categories. Here's how MCK compares to the other S&P 500 stocks.
Dive deeper — all 31 metrics 9 categories · valuation, growth, health, dividends & more Show all Hide
Valuation
Is the stock cheap or expensive relative to its earnings, sales, and assets? Lower multiples often mean better value.
| Metric | Value | vs S&P 500 |
|---|---|---|
| P/E Ratio (Trailing) | 19.54 | Above avg |
| Forward P/E | 14.91 | Above avg |
| PEG Ratio | 1.53 | Above avg |
| Price to Sales | 0.22 | Top 25% |
| Price to Book | -41.47 | Top 25% |
| EV/EBITDA | 14.61 | Above avg |
| Earnings Yield | 5.12% | Above avg |
Profitability
How efficiently does the company turn revenue into profit? Higher margins mean more money kept from each dollar earned.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Gross Margin | 3.60% | Below avg |
| Operating Margin | 2.21% | Below avg |
| Net Profit Margin | 1.18% | Below avg |
| Return on Equity | — | N/A |
| Return on Invested Capital | 4.99% | Average |
Growth
How fast is the business expanding? Strong growth in revenue and earnings signals increasing market demand.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Revenue Growth (YoY) | 6.00% | Average |
| Revenue Growth (3Y CAGR) | 13.39% | Top 25% |
| EPS Growth (YoY) | 37.20% | Above avg |
| Free Cash Flow Growth | 3.52% | Average |
Health
Can the company cover its debts and obligations? A healthy balance sheet reduces the risk of financial trouble.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Current Ratio | 0.85 | Below avg |
| Debt to Equity | — | N/A |
| Interest Coverage | 26.11 | Top 25% |
| Altman Z-Score | 6.03 | Top 25% |
Dividends
Does the company pay shareholders, and is that payment growing and sustainable?
| Metric | Value | vs S&P 500 |
|---|---|---|
| Dividend Yield | 0.42% | Below avg |
| Payout Ratio | 8.26% | Top 25% |
| Dividend Growth (5Y) | -1.62% | Top 25% |
Cash Flow
Is real cash flowing into the business — not just accounting profits? Strong cash flow funds growth and dividends.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Free Cash Flow Yield | 6.16% | Above avg |
| OCF to Sales | 1.53% | Below avg |
Risk
How volatile is the stock compared to the broader market? Lower beta and volatility mean a smoother ride.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Beta (1-Year) | 0.32 | Top 25% |
| Volatility (30-Day) | 24.63% | Above avg |
Sentiment
What do analysts and short-sellers think? High analyst ratings and low short interest signal broad confidence.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Short % of Float | 4.36% | Average |
| Avg. Analyst Rating | 1.47 | Top 25% |
| Target Upside % | 25.41% | Above avg |
Size
How large is the company by market value? Size affects stability, growth potential, and index inclusion.
| Metric | Value | vs S&P 500 |
|---|---|---|
| Market Capitalization | 87.88B | Above avg |
How does MCK compare to…?
Pick another stock and see them side by side in seconds.
You might also look at
Companies in a similar position to MCK — based on their financial profile.